Novartis AG
COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO

Last updated:

Abstract:

The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.

Status:
Application
Type:

Utility

Filling date:

22 Jul 2021

Issue date:

18 Nov 2021